The future of health is not about
responding to illness.

It's about preventing it.

KIFFIK sees a world where diagnostics are no longer reactive, but intuitive — where listening to the body in real time becomes the foundation of preventive, personalized care for everyone. – early, clearly, and without barriers.

We envision a future where diagnostics are not confined to hospitals or triggered by symptoms, but integrated into daily life — intuitive, non-invasive, and informed by the body’s own intelligence. A future where real-time biomarker insights empower people to understand their health and act on it, long before conditions become crises.

Our platform opens the door to a new model of care — one that is proactive, personalized, and accessible to all. Listening to the body should not be a privilege. It should be a universal right.

Our history.

KIFFIK Biomedical was born out of a deeply personal journey married with significant scientific insights. Inventor, Dr. Abdeltif Essalik, sought a solution for monitoring biomarkers for medical applications that was:

Dr. Essalik followed three guiding theories:

  1. Interstitial fluid, which can be accessed from virtually any part of the body, represents an ideal medium for the continuous or periodic monitoring of physiological analytes.
  2. Inserting one or more biosensors into the interstitium is not an optimal approach for the continuous or periodic tracking of biomarkers.
  3. The existing methods for accessing ISF were all invasive and impractical for routine monitoring.

In 2009, Dr. Essalik successfully demonstrated a groundbreaking method for continuous extraction of ISF based on an original and innovative technique of skin electroporation. This became KIFFIK’s first patent and established a foundation from which KIFFIK could build and continue to innovate.

A new model of care.

“With first-of-its kind technology, you need a team with demonstrated leadership & proven success across the business spectrum.  The team we’ve built at KIFFIK collectively has more than 200 years of experience and is a proven collective of excellence.  We are smart, nimble & committed to successfully bringing the KIFFIK innovations to market.”

– George Cagna, CEO

Our history.

KIFFIK Biomedical was born out of a deeply personal journey married with significant scientific insights. Inventor, Dr. Abdeltif Essalik, sought a solution for monitoring biomarkers for medical applications that was:

Dr. Essalik followed three guiding theories:

  1. Interstitial fluid, which can be accessed from virtually any part of the body, represents an ideal medium for the continuous or periodic monitoring of physiological analytes.
  2. Inserting one or more biosensors into the interstitium is not an optimal approach for the continuous or periodic tracking of biomarkers.
  3. The existing methods for accessing ISF were all invasive and impractical for routine monitoring.

In 2009, Dr. Essalik successfully demonstrated a groundbreaking method for continuous extraction of ISF based on an original and innovative technique of skin electroporation. This became KIFFIK’s first patent and established a foundation from which KIFFIK could build and continue to innovate. 

Our news.

  • All Posts
  • Articles
  • Awards
  • Funding
  • Medicine
  • Newsletter
  • Press Releases
  • Technology
December News

December 21, 2023/

KIFFIK Biomedical secures a pivotal $50 million investment from GEM Global Yield, positioning the company as a ‘Unicorn-in-Waiting’ KIFFIK’s patented...

October 10, 2023/

KIFFIK Biomedical Secures Strategic $50 Million Capital Commitment from GEM

Load More

End of Content.